From Inhibition to Degradation: Targeting the Antiapoptotic Protein Myeloid Cell Leukemia 1 (MCL1)-Reference-Cited by-同舟云学术

From Inhibition to Degradation: Targeting the Antiapoptotic Protein Myeloid Cell Leukemia 1 (MCL1)

Published:2019-05-22 Issue:11 Volume:62 Page:5522-5540
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Papatzimas James W.¹,Gorobets Evgueni¹,Maity Ranjan¹,Muniyat Mir Ishruna,MacCallum Justin L.^ORCID,Neri Paola¹,Bahlis Nizar J.¹,Derksen Darren J.¹^ORCID

Affiliation:

1. Arnie Charbonneau Cancer Institute, University of Calgary, 3280 Hospital Drive NW, T2N 4Z6 Calgary, Alberta, Canada

Funder

Government of Canada

Multiple Myeloma Research Foundation

Alberta Children's Hospital Foundation

Alberta Innovates - Technology Futures

Canada Research Chairs Program

Arnie Charbonneau Cancer Institute, University of Calgary

Alberta Children's Hospital Research Institute

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.9b00455

Reference68 articles.

1. The landscape of somatic copy-number alteration across human cancers

2. The Bcl2 family: regulators of the cellular life-or-death switch

3. Mitochondria and cell death: outer membrane permeabilization and beyond

4. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy

5. Bone marrow microenvironment–derived signals induce Mcl-1 dependence in multiple myeloma

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the ubiquitin pathway in lymphoid malignancies;Cancer Letters;2024-07

2. Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges;Acta Pharmaceutica Sinica B;2024-06

3. Anticancer Therapy with Proteolysis-targeting Chimeras [PROTACs] Targeting Towards the Tumor-microenvironment: Development, Current State and Prospects;Current Cancer Therapy Reviews;2024-05-14

4. Targeting Myeloid Leukemia-1 in Cancer Therapy: Advances and Directions;Journal of Medicinal Chemistry;2024-04-10

5. B‐cell lymphoma‐2 family proteins in the crosshairs: Small molecule inhibitors and activators for cancer therapy;Medicinal Research Reviews;2023-11-20